PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue139,989197,701485,879487,463
Cost of Revenue30,5374,065--
Gross Profit109,452193,636485,879487,463
Operating Expenses
Research Development7,3813,8203,8203,820
Selling General and Administrative63,32440,32836,09034,914
Non Recurring----
Others----
Total Operating Expenses125,93160,24136,09034,914
Operating Income or Loss14,058137,460449,789452,549
Income from Continuing Operations
Total Other Income/Expenses Net170,469-28,09080,34948,723
Earnings Before Interest and Taxes14,058137,460449,789452,549
Interest Expense-20,221-18,267-27,059-39,211
Income Before Tax184,527109,370530,138501,272
Income Tax Expense73,82645,711197,343179,028
Minority Interest-4,2804,2804,280
Net Income From Continuing Ops110,70163,659332,795322,244
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income110,74863,606332,795322,244
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares110,74863,606332,795322,244